Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Novartis N Ord (0QLR) Share Price

Price 114.03 on 08-01-2026 at 19:30:04
Change 0.05 0.04%
Buy 116.88
Sell 111.18
Last Trade: Unknown 82,400.00 at 113.70
Day's Volume: 930,642
Last Close: 114.03
Open: 114.09
ISIN: CH0012005267
Day's Range 111.24 - 114.09
52wk Range: 81.23 - 114.09
Market Capitalisation: -
VWAP: 114.00396
Shares in Issue: 1.92b

Novartis N Ord (0QLR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 82,400 113.70 OTC Trade
17:56:30 - 08-Jan-26
Unknown* 2,975 113.73725 OTC Trade
17:48:26 - 08-Jan-26
Unknown* 12 114.04974 OTC Trade
17:40:54 - 08-Jan-26
Unknown* 353 113.91071 SI Trade
Negotiated Trade
17:38:24 - 08-Jan-26
Unknown* 4,916 113.88645 OTC Trade
17:30:41 - 08-Jan-26
Unknown* 41,530 113.90809 OTC Trade
17:30:35 - 08-Jan-26
Unknown* 21,684 113.99393 OTC Trade
17:30:34 - 08-Jan-26
Unknown* 12,384 113.76 OTC Trade
17:26:38 - 08-Jan-26
Unknown* 3,500 113.76 OTC Trade
17:26:00 - 08-Jan-26
Unknown* 73,762 113.76 OTC Trade
17:18:47 - 08-Jan-26
See more Novartis N Ord trades

Novartis N Ord (0QLR) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Jan 2026 (Thu) 114.09 114.09 111.24 114.03 930,642
7th Jan 2026 (Wed) 112.08 113.98 109.28 113.98 1,200,714
6th Jan 2026 (Tue) 109.18 110.95 106.46 110.95 2,014,501
5th Jan 2026 (Mon) 109.80 109.80 107.06 108.84 471,458
2nd Jan 2026 (Fri) 109.45 109.45 109.45 109.45 128
1st Jan 2026 (Thu) 109.45 109.45 109.45 109.45 0
31st Dec 2025 (Wed) 109.45 109.45 109.45 109.45 0
30th Dec 2025 (Tue) 109.70 109.70 106.96 109.45 374,352
29th Dec 2025 (Mon) 109.66 109.74 106.92 109.74 172,112
26th Dec 2025 (Fri) 110.56 110.56 110.56 110.56 0
25th Dec 2025 (Thu) 110.56 110.56 110.56 110.56 0
24th Dec 2025 (Wed) 110.56 110.56 110.56 110.56 787,160
23rd Dec 2025 (Tue) 108.94 110.56 106.22 110.56 2,383,866
22nd Dec 2025 (Mon) 108.10 108.10 105.40 107.95 1,954,154
19th Dec 2025 (Fri) 108.12 108.12 105.42 108.10 2,597,555
18th Dec 2025 (Thu) 107.58 107.58 104.90 107.40 485,182
17th Dec 2025 (Wed) 107.42 107.42 104.74 107.34 583,057
16th Dec 2025 (Tue) 108.53 108.53 105.82 108.26 599,178
15th Dec 2025 (Mon) 105.25 106.78 102.62 106.78 144,153
12th Dec 2025 (Fri) 105.39 105.39 102.76 105.31 361,964
11th Dec 2025 (Thu) 105.12 105.12 102.50 105.00 2,347,224
10th Dec 2025 (Wed) 106.11 106.11 103.46 105.78 989,736
9th Dec 2025 (Tue) 106.56 106.72 103.90 106.72 995,915
8th Dec 2025 (Mon) 107.17 107.61 104.50 107.61 1,263,648
See more Novartis N Ord price history

Novartis N Ord (0QLR) Share News

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

24th Jul 2019 10:34

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a Read More

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

1st Jul 2019 09:13

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replacing Philip Richards, who will retire in Read More

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

24th May 2019 09:35

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU Read More

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

26th Mar 2019 12:07

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in Japan.Oxford BioMedica is the sole of in Read More

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

20th Feb 2019 10:25

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight Abbreviated New Drug Applications from Sandoz a Read More

See more Novartis N Ord news
FTSE 100 Latest
Value10,044.69
Change-3.52

Login to your account

Forgot Password?

Not Registered